Oaktree Acquisition Corp III Life Sciences - Class A
Research Oaktree Acquisition Corp III Life Sciences - Class A (OACC) on Bullrun: market cap USD 264.27M, P/E 39.1. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOACC
- ExchangeNASDAQ
- CountryUnited States
- SectorFinancial Services
- IndustryShell Companies
- CurrencyUSD
- Market capUSD 264.27M
- P/E39.1
- Financial periodQ2 2026
- RevenueUSD 0
- Net incomeUSD 1.60M
- Free cash flow-USD 97.26K
Valuation Snapshot
latest market cap is USD 264.27M; P/E is 39.1.
Peer valuation comparison
Latest P/E is 39.12x versus a Financial Services sector median of 13.41x (191.7% above).
Latest P/E is 39.12x versus a United States median of 23.75x (64.7% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | USD 7.29M | -USD 422.08K | n/a | 0.3 | USD 1.43M | USD 11.82K | -USD 6.77M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 264.27M | 39.1 | n/a | n/a |
| 2025 | 2025-12-31 | USD 260.09M | 35.3 | n/a | n/a |
| 2024 | 2024-12-31 | USD 244.84M | 199.2 | n/a | n/a |
About Oaktree Acquisition Corp III Life Sciences - Class A
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
Related stock research
Other Financial Services stocks
Frequently asked questions
What is Oaktree Acquisition Corp III Life Sciences - Class A's market cap?
Oaktree Acquisition Corp III Life Sciences - Class A's market capitalization is USD 264.27M.
What is Oaktree Acquisition Corp III Life Sciences - Class A's P/E ratio?
Oaktree Acquisition Corp III Life Sciences - Class A's price-to-earnings (P/E) ratio is 39.1.
What does Oaktree Acquisition Corp III Life Sciences - Class A do?
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.